Published in Clin Gastroenterol Hepatol on April 15, 2011
Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies. Clin Gastroenterol Hepatol (2012) 0.96
Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort. Hepatology (2016) 0.89
Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. World J Gastroenterol (2013) 0.84
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med (2013) 0.82
NAFLD and liver transplantation: Current burden and expected challenges. J Hepatol (2016) 0.81
Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation. Dig Dis Sci (2016) 0.81
A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. World J Gastroenterol (2012) 0.80
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World J Gastroenterol (2017) 0.79
Acute-on-chronic liver failure. Clin Liver Dis (2014) 0.79
Nonalcoholic fatty liver disease: what are the odds your patient will get a transplant? Clin Gastroenterol Hepatol (2011) 0.75
Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation. Dig Dis Sci (2017) 0.75
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46
Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology (2008) 2.23
Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend (2004) 1.91
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology (2003) 1.76
Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl (2010) 1.70
Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology (Berl) (2005) 1.70
Twenty years of follow-up of aortohepatic conduits in liver transplantation. Liver Transpl (2008) 1.53
Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation (2004) 1.50
Syndromic incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer. Dig Dis Sci (2003) 1.43
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology (2002) 1.40
High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients. J Am Coll Cardiol (2003) 1.39
Assessing water quality at large geographic scales: relations among land use, water physicochemistry, riparian condition, and fish community structure. Environ Manage (2003) 1.38
Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol (2010) 1.35
Economic model of a birth cohort screening program for hepatitis C virus. Hepatology (2012) 1.28
Indications for liver transplantation. Gastroenterology (2008) 1.28
Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24
Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation. Liver Transpl (2009) 1.22
Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent) (2008) 1.20
A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl (2003) 1.20
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl (2012) 1.18
Compositional analysis of lignocellulosic materials: evaluation of methods used for sugar analysis of waste paper and straw. Bioresour Technol (2006) 1.14
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation (2010) 1.13
An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score. Transpl Int (2006) 1.11
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2007) 1.10
Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant (2003) 1.05
De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00
Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation. Liver Transpl (2004) 1.00
Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl (2007) 0.99
Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills? Liver Transpl (2006) 0.98
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97
Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Transplantation (2006) 0.96
Late acute rejection after liver transplantation impacts patient survival. Clin Transplant (2008) 0.96
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl (2004) 0.96
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial. Liver Transpl (2004) 0.93
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy. Antivir Ther (2006) 0.93
Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl (2007) 0.93
Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. Nutr Clin Pract (2013) 0.92
Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transpl (2011) 0.90
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl (2002) 0.90
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl (2002) 0.90
Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients. Ann Surg (2004) 0.90
Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl (2002) 0.90
The prevalence of hepatitis C virus infection in Texas: implications for future health care. Proc (Bayl Univ Med Cent) (2005) 0.89
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation (2003) 0.89
Future trends in hepatology: challenges and opportunities. Hepatology (2008) 0.89
Liver transplantation and health-related quality of life: scoring differences between men and women. Liver Transpl (2004) 0.88
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation (2002) 0.88
Clinical outcomes from hepatic artery stenting in liver transplantation. Liver Transpl (2006) 0.87
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease. Liver Transpl (2009) 0.87
Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation--a clinical and histological examination. Clin Transplant (2006) 0.86
Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis. Ann Hepatol (2009) 0.86
A microplate assay specific for the enzyme aggrecanase. Anal Biochem (2003) 0.85
Intraductal oncocytic papillary neoplasm of the liver: case and review of a rare variant. Ann Hepatol (2008) 0.85
Indications for combined liver and kidney transplantation: propositions after a 23-yr experience. Clin Transplant (2010) 0.85
The MELD score in advanced liver disease: association with clinical portal hypertension and mortality. Exp Clin Transplant (2006) 0.85
Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients. Liver Transpl (2014) 0.84
Hepatitis C screening: summary of recommendations from the clinical decision tool. Gastroenterology (2013) 0.83
Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients. Liver Transpl (2013) 0.83
Tailoring antiviral therapy in hepatitis C. Hepatology (2006) 0.83
Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C. Am J Gastroenterol (2003) 0.82
Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant (2002) 0.82
Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2009) 0.82
Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population. Pediatr Transplant (2003) 0.82
Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection. Liver Transpl (2003) 0.81
Fundamental differences in bioaffinity of amino acid dehydrogenases for N6- and S6-linked immobilized cofactors using kinetic-based enzyme-capture strategies. Anal Biochem (2005) 0.81
Post-liver transplant survival in hepatitis C patients is improving over time. Liver Transpl (2009) 0.81
Hepatitis C virus: a critical appraisal of approaches to therapy. Clin Gastroenterol Hepatol (2008) 0.81
Deciding liver transplant candidacy: tools of the trade. Liver Int (2008) 0.80
Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Liver Transpl (2003) 0.80
Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined. Transpl Int (2012) 0.80
Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens. Clin Transplant (2007) 0.80
Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria. Transplantation (2005) 0.79
Successful combined liver and kidney transplant for COACH syndrome and 5-yr follow-up. Clin Transplant (2005) 0.79
Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology. Transplantation (2011) 0.79
Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody. Clin Transplant (2002) 0.79
Sirolimus and cardiovascular disease risk in liver transplantation. Transplantation (2013) 0.78
Twenty years' follow-up of portal vein conduits in liver transplantation. Liver Transpl (2009) 0.78
Intraoperative imaging of pancreas transplant allografts using indocyanine green with laser fluorescence. Proc (Bayl Univ Med Cent) (2008) 0.78
Baylor Regional Transplant Institute: an update on liver, kidney, and pancreas transplantation. Proc (Bayl Univ Med Cent) (2003) 0.78
Hepatitis C virus replication and potential targets for direct-acting agents. Therap Adv Gastroenterol (2010) 0.77
Results of live donor liver transplantation in patients with hepatitic C virus infection: the HCV 3 trial experience. Clin Transplant (2011) 0.77
Implications of a positive crossmatch in liver transplantation: a 20-year review. Liver Transpl (2012) 0.77
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C. Clin Gastroenterol Hepatol (2008) 0.77
Rapid virological response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virological response and relapse in genotype 1 patients. Therap Adv Gastroenterol (2009) 0.77
The challenge of progressive hepatitis C following liver transplantation. Liver Transpl (2006) 0.77
Liver transplantation for cystic fibrosis in adults. Surg Today (2007) 0.76
Inferior vena cava stent resolves hepatopulmonary syndrome in an adult with a spontaneous inferior vena cava-portal vein shunt. Liver Transpl (2009) 0.76
The evolving treatment of chronic hepatitis C: where we stand a decade out. Cleve Clin J Med (2004) 0.76
Management of ascites in patients with end-stage liver disease. Rev Gastroenterol Disord (2004) 0.76
Impact of birth cohort screening for hepatitis C. Curr Gastroenterol Rep (2014) 0.76
Ratio of hepatic arterial flow to recipient body weight predicts biliary complications after deceased donor liver transplantation. HPB (Oxford) (2014) 0.75
Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation. Proc (Bayl Univ Med Cent) (2011) 0.75